Literature DB >> 27173597

Different parvalbumin and GABA expression in human epileptogenic focal cortical dysplasia.

Valentina Medici1, Laura Rossini1, Francesco Deleo1, Giovanni Tringali2, Laura Tassi3, Francesco Cardinale3, Manuela Bramerio4, Marco de Curtis1, Rita Garbelli1, Roberto Spreafico1.   

Abstract

OBJECTIVE: Several studies have reported that inhibitory networks are altered in dysplastic tissue obtained from epilepsy surgery specimens. A consistent decrease in the number of inhibitory interneuronal subpopulation that expresses parvalbumin (PV) was reported in postsurgical tissue from patients with focal cortical dysplasia (FCD). We tested if the decrease in PV protein expression observed in epileptic tissue corresponds to a parallel impairment in the γ-aminobutyric acid (GABA)ergic compartment.
METHODS: We analyzed postsurgical tissue from 30 surgically treated patients who underwent surgery for intractable epilepsy including 26 patients with FCD (types I, II, and III) and 4 patients without any microscopic visible lesion (cryptogenic) as controls. Serial sections were processed using in situ hybridization with GAD-65 and GAD-67 probes and immunocytochemistry with antibody against PV. The density of inhibitory PV-immunoreactive interneurons in relation to GABAergic cells was estimated in controls and in all different pathologic groups by using a two- and three-dimensional (2D and 3D) cell-counting technique. Field fraction and line profile analyses were added to estimate immunostaining proportion and distribution of PV signal generated in gray matter.
RESULTS: A reduction of PV-positive cells and PV-immunoreactivity was observed exclusively in FCD type I/III specimens compared with cryptogenic tissue from control patients with a poor postsurgical outcome. In FCD type II, a profound rearrangement in the cortical distribution of PV immunoreactivity was observed, without a quantitative reduction of the number of neurons and terminals. In situ hybridization did not reveal significant variations of GAD expression in any FCD subtype. SIGNIFICANCE: Our study suggests a preservation of inhibitory networks in FCD postsurgical tissue, demonstrated by a substantial normal count of GABAergic neurons. A selective PV expression impairment is demonstrated in FCD type I and III and an abnormal, but not reduced, distribution of PV cells and terminals is confirmed in type II FCD. Possible functional consequences are discussed. Wiley Periodicals, Inc.
© 2016 International League Against Epilepsy.

Entities:  

Keywords:  Epilepsy; GAD-65/67 riboprobes; Immunohistochemistry; Inhibitory network

Mesh:

Substances:

Year:  2016        PMID: 27173597     DOI: 10.1111/epi.13405

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

1.  Differential Expression Hallmarks of Interneurons in Different Types of Focal Cortical Dysplasia.

Authors:  Chao Liang; Chun-Qing Zhang; Xin Chen; Lu-Kang Wang; Jiong Yue; Ning An; Lei Zhang; Shi-Yong Liu; Hui Yang
Journal:  J Mol Neurosci       Date:  2020-02-08       Impact factor: 3.444

2.  GABAergic Interneuron and Neurotransmission Are mTOR-Dependently Disturbed in Experimental Focal Cortical Dysplasia.

Authors:  Shaoping Zhong; Zhihao Zhao; Wanjing Xie; Yiying Cai; Yiying Zhang; Jing Ding; Xin Wang
Journal:  Mol Neurobiol       Date:  2020-09-10       Impact factor: 5.590

3.  Can histologically normal epileptogenic zone share common electrophysiological phenotypes with focal cortical dysplasia? SEEG-based study in MRI-negative epileptic patients.

Authors:  Stanislas Lagarde; Julia Scholly; Irina Popa; Maria Paola Valenti-Hirsch; Agnès Trebuchon; Aileen McGonigal; Mathieu Milh; Anke M Staack; Béatrice Lannes; Benoît Lhermitte; François Proust; Mustapha Benmekhbi; Didier Scavarda; Romain Carron; Dominique Figarella-Branger; Edouard Hirsch; Fabrice Bartolomei
Journal:  J Neurol       Date:  2019-05-04       Impact factor: 4.849

4.  Loss of putative GABAergic neurons in the ventrolateral medulla in multiple system atrophy.

Authors:  Ann M Schmeichel; Elizabeth A Coon; Joseph E Parisi; Wolfgang Singer; Phillip A Low; Eduardo E Benarroch
Journal:  Sleep       Date:  2021-09-13       Impact factor: 6.313

5.  Contributions of EEG-fMRI to Assessing the Epileptogenicity of Focal Cortical Dysplasia.

Authors:  Francesca Pittau; Lorenzo Ferri; Firas Fahoum; François Dubeau; Jean Gotman
Journal:  Front Comput Neurosci       Date:  2017-02-20       Impact factor: 2.380

6.  Spectral bandwidth of interictal fast epileptic activity characterizes the seizure onset zone.

Authors:  Marcel Heers; Moritz Helias; Tanguy Hedrich; Matthias Dümpelmann; Andreas Schulze-Bonhage; Tonio Ball
Journal:  Neuroimage Clin       Date:  2017-11-26       Impact factor: 4.881

7.  INTERNEURONOPATHIES AND THEIR ROLE IN EARLY LIFE EPILEPSIES AND NEURODEVELOPMENTAL DISORDERS.

Authors:  Anna-Maria Katsarou; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Epilepsia Open       Date:  2017-06-28

8.  Laminar Distribution of Neurochemically-Identified Interneurons and Cellular Co-expression of Molecular Markers in Epileptic Human Cortex.

Authors:  Qiyu Zhu; Wei Ke; Quansheng He; Xiongfei Wang; Rui Zheng; Tianfu Li; Guoming Luan; Yue-Sheng Long; Wei-Ping Liao; Yousheng Shu
Journal:  Neurosci Bull       Date:  2018-08-31       Impact factor: 5.203

Review 9.  Cortical Malformations: Lessons in Human Brain Development.

Authors:  Lakshmi Subramanian; Maria Elisa Calcagnotto; Mercedes F Paredes
Journal:  Front Cell Neurosci       Date:  2020-01-24       Impact factor: 5.505

10.  Post-Surgical Outcome and Its Determining Factors in Patients Operated on With Focal Cortical Dysplasia Type II-A Retrospective Monocenter Study.

Authors:  Attila Rácz; Albert J Becker; Carlos M Quesada; Valeri Borger; Hartmut Vatter; Rainer Surges; Christian E Elger
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.